Lys441
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1.1
Powered by Cell Signaling Technology
Home > Acetylation Site Page: > Lys441  -  PCAF (human)

Site Information
SHVLEEAkkPRVMGD   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 458987

In vivo Characterization
Methods used to characterize site in vivo:
modification-specific antibody ( 1 ) , western blotting ( 1 )
Disease tissue studied:
bone cancer ( 1 )
Relevant cell line - cell type - tissue:
U2OS (bone cell) ( 1 )

Downstream Regulation
Effects of modification on PCAF:
enzymatic activity, induced ( 1 )

References 

1

Santos-Rosa H, Valls E, Kouzarides T, Martínez-Balbás M (2003) Mechanisms of P/CAF auto-acetylation. Nucleic Acids Res 31, 4285-92
12888487   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2019 Cell Signaling Technology, Inc.